Skip to Main Content

Good morning, everyone, and nice to see you again after the extended, year-end break. We hope you had a chance to enjoy the respite. Nothing like a little time to enjoy and contemplate, yes? Now, though, the familiar routine of meetings, deadlines, and whatnot has returned. You knew this was coming, after all. So please join us as we quaff the mandatory cups of stimulation. And, as always, here are some catch-up tidbits. Hope your year gets off to a smashing start and please do stay in touch. We enjoy the tips and insights. Have a great day …

Shire is in advanced talks to acquire Baxalta for about $32 billion in cash and stock, but excluding debt, according to Bloomberg News. A deal may be announced as soon as this week. Last summer, Baxalta rejected a $30 billion all-stock bid. Shire, you may recall, has been focusing on acquiring companies with treatments for rare conditions and paid $5.9 billion for Dyax in November and $5 billion for NPS Pharmaceuticals in February.


China Animal Healthcare, which is partly owned by Eli Lilly, disclosed it was searching for five years worth of financial documents that were lost after a truck carrying the records was stolen as the driver took a lunch break, Reuters reported. The documents were stolen while in transit from a storage facility in China’s northern Hebei province to the company’s headquarters in nearby Beijing.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!